Understanding barriers and optimizing socio‐cognitive assessment in the diagnosis of neurocognitive disorders. Cerami, C., Boccardi, M., Meli, C., Panzavolta, A., Funghi, G., Festari, C., Cappa, S. F., Chatzikostopoulos, T., Chicherio, C., Clarens, F., de Oliveira, F. F., Lorenzo, F. D., Filardi, M., Ibanez, A., Girtler, N., Lebouvier, T., Logroscino, G., Luca, A., MacPherson, S. E., Matias‐Guiu, J. A., Piccoli, T., Piguet, O., Pomati, S., Russo, M., Sacco, L., Schild, A., Sensi, S. L., Shirk, S. D., Sollberger, M., Tábuas‐Pereira, M., Tsolaki, M., van den Berg, E., Bertoux, M., Kumfor, F., den Stock, J. V., Welsh‐Bohmer, K. A., & Dodich, A. Journal of Neuropsychology, 19:603-618, 9, 2025.
Understanding barriers and optimizing socio‐cognitive assessment in the diagnosis of neurocognitive disorders [link]Paper  doi  abstract   bibtex   

Harmonized neuropsychological assessment for neurocognitive disorders (NCDs) is an urgent priority in clinics. Neuropsychology assessments in NCDs seldom include tests exploring social cognitive skills. In 2022, we launched the SIGNATURE initiative to optimize socio‐cognitive assessment in NCDs. Here, we report findings from the first initiative phase, including consortium creation and evaluation of the state of the art in socio‐cognitive assessment in memory clinics. We developed an ad hoc online survey to explore practices and measures, relevance, and obstacles preventing the use of socio‐cognitive testing in clinics. The survey was distributed within the SIGNATURE network. National coordinators were identified to disseminate the survey to local collaborators and scientific societies active in the field of dementia and/or neuropsychology. Data were analysed in aggregate form and stratified by geographical area and variables of interest. Four hundred and thirteen (413) responses from 10 European and Latin American geographical regions were recorded. Responders were balanced between physicians and psychologists. Seventy‐eight (78) % of respondents reported no/limited experience with socio‐cognitive measures; more than 85% agreed on their relevance in clinics. Ekman‐60 faces was the most well‐known and/or used task, followed by the Faux‐Pas and Reading‐the‐Mind‐in‐the‐Eyes tests. Lack of clinical measures, assessment time, guidelines, and education/training were reported as main obstacles. Real‐life barriers prevent the adoption of socio‐cognitive testing in clinics. Bidirectional collaboration between clinicians and researchers is required to address clinical needs and constraints and facilitate consistent socio‐cognitive assessment.

@article{Cerami2025,
   abstract = {<p> Harmonized neuropsychological assessment for neurocognitive disorders (NCDs) is an urgent priority in clinics. Neuropsychology assessments in NCDs seldom include tests exploring social cognitive skills. In 2022, we launched the <italic>SIGNATURE</italic> initiative to optimize socio‐cognitive assessment in NCDs. Here, we report findings from the first initiative phase, including consortium creation and evaluation of the state of the art in socio‐cognitive assessment in memory clinics. We developed an ad hoc online survey to explore practices and measures, relevance, and obstacles preventing the use of socio‐cognitive testing in clinics. The survey was distributed within the <italic>SIGNATURE</italic> network. National coordinators were identified to disseminate the survey to local collaborators and scientific societies active in the field of dementia and/or neuropsychology. Data were analysed in aggregate form and stratified by geographical area and variables of interest. Four hundred and thirteen (413) responses from 10 European and Latin American geographical regions were recorded. Responders were balanced between physicians and psychologists. Seventy‐eight (78) % of respondents reported no/limited experience with socio‐cognitive measures; more than 85% agreed on their relevance in clinics. Ekman‐60 faces was the most well‐known and/or used task, followed by the Faux‐Pas and Reading‐the‐Mind‐in‐the‐Eyes tests. Lack of clinical measures, assessment time, guidelines, and education/training were reported as main obstacles. Real‐life barriers prevent the adoption of socio‐cognitive testing in clinics. Bidirectional collaboration between clinicians and researchers is required to address clinical needs and constraints and facilitate consistent socio‐cognitive assessment. </p>},
   author = {Chiara Cerami and Marina Boccardi and Claudia Meli and Andrea Panzavolta and Giulia Funghi and Cristina Festari and Stefano F. Cappa and Thanos Chatzikostopoulos and Christian Chicherio and Florencia Clarens and Fabricio Ferreira de Oliveira and Francesco Di Lorenzo and Marco Filardi and Agustin Ibanez and Nicola Girtler and Thibaud Lebouvier and Giancarlo Logroscino and Antonella Luca and Sarah E. MacPherson and Jordi A. Matias‐Guiu and Tommaso Piccoli and Olivier Piguet and Simone Pomati and Mirella Russo and Leonardo Sacco and Ann‐Katrin Schild and Stefano L. Sensi and Steven D. Shirk and Marc Sollberger and Miguel Tábuas‐Pereira and Magda Tsolaki and Esther van den Berg and Maxime Bertoux and Fiona Kumfor and Jan Van den Stock and Kathleen A. Welsh‐Bohmer and Alessandra Dodich},
   doi = {10.1111/jnp.12431},
   issn = {1748-6645},
   issue = {3},
   journal = {Journal of Neuropsychology},
   month = {9},
   pages = {603-618},
   title = {Understanding barriers and optimizing socio‐cognitive assessment in the diagnosis of neurocognitive disorders},
   volume = {19},
   url = {https://bpspsychub.onlinelibrary.wiley.com/doi/10.1111/jnp.12431},
   year = {2025}
}

Downloads: 0